Norepinephrine Bitartrate Injection, Solution
Product Images NDC 83634-307

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 83634-307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avenacy, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Nor0v 0000 01)

Chemical structure of norepinephrine bitartrate showing the molecular arrangement of norepinephrine coupled with a bitartrate moiety, including hydroxyl groups, amine, carboxyl, and water molecules.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL – Vial Label)

Label for norepinephrine bitartrate injection, USP, 1 mg/mL in 4 mL single-dose vial (total 4 mg per 4 mL). Indicated for intravenous infusion only, contains sulfites warning. Labeler is Avenacy, LLC, with manufacturing information for Avenacy in Schamburg, IL, and India. Includes NDC 83634-307-41 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.